Finally, because FNIII EDA can induce cellular immune responses including activation of CD8+ T cell responses26, 27, 28, 29, 30, 31, the domain has also been explored as a cancer vaccine adjuvant in mouse models28, 30, 31. Here, CD8A is linked to cancer.